Statistics

Cannabis Use in Sub-Saharan Africa

Belete, H., Mekonen, T., Espinosa, D. C., Ambaw, F., Connor, J., Chan, G., ... & Leung, J. (2023). Cannabis use in Sub‐Saharan Africa: a systematic review and meta‐analysis. Addiction.

Abstract

Background and Aims

The most available data on the prevalence of cannabis use come from population surveys conducted in high-income countries in North America, Oceania and Europe. Less is known about the prevalence of cannabis use in Africa. This systematic review aimed to summarize general population-level cannabis use in sub-Saharan Africa since 2010.

Risk Behaviour of Adolescents Aged 10–15 in Slovakia. Relation to Sex, Age, and Body Mass Index

Čerešník, M., & Čerešníková, M. (2022). Risk behaviour of adolescents aged 10–15 in Slovakia. Relation to sex, age, and body mass index. Adiktologie, 22(3), 162–170. https://doi.org/10.35198/01-2022-003-0001
Publication Date

BACKGROUND: As a theoretical base we used Jessor’s concept of the Syndrome of Risk Behaviour in Adolescence, the self-concept, and the concept of body image.

Gender, employment, and continuous pandemic as predictors of alcohol and drug consumption during the COVID-19.

Levy, I., Cohen-Louck, K., & Bonny-Noach, H. (2021). Gender, employment, and continuous pandemic as predictors of alcohol and drug consumption during the COVID-19. Drug and Alcohol Dependence, 228 ,109029.
Publication Date

Aims

This study aims to assess the impacts of the continuous pandemic state, gender and employment status on changes in substance use during the COVID-19 outbreak.

Substances use between early and later stages of the COVID 19 pandemic in Israel

10) Bonny-Noach, H., Cohen-Louck, K., & Levy, I. (2021). Substances use between early and later stages of the COVID 19 pandemic in Israel. Israel Journal of Health Policy Research, 9, 52.
Publication Date

Aims

Only several empirical studies have examined substance use during the COVID-19 pandemic in general populations. Most of these studies compared self-reported substances use before the pandemic and during the pandemic's early stages. This study aims to identify the changes in substance use between the early and later waves of the COVID-19 pandemic in Israel.

How wastewater monitoring can boost preparedness for new health threats

Created by
EMCDDA

Objective: to explore wastewater analysis as a methodology contributing to EU preparedness and response

Background: COVID-19 has raised the attention of Europe, and globally, on the importance of readiness towards potential emergencies. Improved and innovative monitoring methodologies are at the core of the research-based actions taken to respond to potential threats.

Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada

Foreman-Mackey, A., Pauly, B., Ivsins, A. et al. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada. Subst Abuse Treat Prev Policy 17, 66 (2022). https://doi.org/10.1186/s13011-022-00494-y
Publication Date

Background

Novel public health interventions are needed to address the toxic drug supply and meet the needs of people who use drugs amidst the overdose crisis.

Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia

Formánek, T., Krupchanka, D., Mladá, K., Winkler, P., & Jones, P. B. (2022). Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia. The Lancet Psychiatry.
Publication Date
Summary

Background

Substance use disorders constitute a major global public health problem, attributable largely to their subsequent comorbidity with other health conditions.